Subsequently, the SubMap analysis was conducted to compare the expression characteristics of FPTOS_score acquired from the TCGA and GEO databases with an open-access metastatic melanoma cohort who receiving anti-PD-1 or anti-CTLA-4 treatment. The gene discussed is CTLA4; the disease is metastatic melanoma.